Bringing Covid-19 therapeutic solutions to the clinic and market with speed, precision and scalability is now a challenge with unparalleled consequence. Ajinomoto Bio-Pharma Services remains committed to helping customers address the global demand for a solution.
Utilize our state-of-the-art manufacturing facilities, technical expertise and innovative GMP compliant processes to support a broad range of molecule types:
- Monoclonal Antibodies
- Recombinant Proteins
- Recombinant DNA
- Plasmid DNA
- Small Molecules
See an overview of the Analytical, Regulatory, and Formulation Services - along with the Vial and Syringe filling capabilities as we respond to the COVID-19 pandemic.